Planning The Execution Of A Viral Clearance Study

Viral clearance studies are done to evaluate a purification process’s capability, or to remove/neutralize viruses that can contaminate a starting material in regulatory submissions in clinical trials. The complexity of these studies means that they typically require significant financial and scientific expertise to perform. Because of this, if a viral clearance study isn’t done right the first time, costly delays are all but inevitable. This white paper outlines what questions you should be asking to ensure a successful study in order to avoid said delays, and to minimize the chances of an unpleasant surprise during the execution of the study.